_id

691054f0ccc777a4e85d559f

Ticker

CRNX

Name

Crinetics Pharmaceuticals Inc

Exchange

NASDAQ

Address

6055 Lusk Boulevard, San Diego, CA, United States, 92121

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.crinetics.com

Description

Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist, which is in a Phase 3 clinical trial for the treatment of acromegaly and carcinoid syndrome associated with neuroendocrine tumors. It is also developing Atumelnant, an investigational oral nonpeptide product candidate to antagonize the adrenocorticotrophic hormone (ACTH) receptor that has completed a Phase 1 study for the treatment of diseases caused by excess ACTH, including congenital adrenal hyperplasia and cushing's disease; and CRN09682, a nonpeptide drug conjugate for SST2 positive solid tumors. In addition, the company is developing antagonists of the parathyroid hormone (PTH) receptor for the treatment of primary hyperparathyroidism and humoral hypercalcemia of malignancy, and other diseases of excess PTH; thyroid-stimulating hormone receptor antagonists for the treatment of graves' disease and thyroid eye disease; SST3 Agonist program for the treatment for autosomal dominant polycystic kidney disease; and Radionetics for multiple solid-tumors, as well as Oral GLP-1 and Oral GIP nonpeptides for the treatment of obesity. The company has an agreement with Sanwa Kagaku Kenkyusho Co., Ltd to develop and commercialize Paltusotine in Japan, and Cellular Longevity, Inc. to develop and commercialize CRN01941, a somatostatin receptor type 2 agonist. Crinetics Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in San Diego, California.

Last Close

49.31

Volume

726785

Current Price

50.49

Change

2.3930237274386528

Last Updated

2025-11-29T11:51:48.090Z

Image

-

Ipo Date

2018-07-18T00:00:00.000Z

Market Cap

4323272192

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9099916666666665

Sentiment Sources

12

Rating

4.5882

Target Price

80.2143

Strong Buy

11

Buy

5

Hold

1

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

143000

Cost Of Revenue

90464000

Gross Profit

-90321000

Operating Expenses

52265000

Operating Income

-142586000

Interest Expense

-

Pretax Income

-130091000

Net Income

-130091000

Eps

-1.3807886217693572

Dividends Per Share

-

Shares Outstanding

94891840

Income Tax Expense

-

EBITDA

-129079000

Operating Margin

-99710.48951048951

Total Other Income Expense Net

12495000

Cash

110901000

Short Term Investments

981390000

Receivables

-

Inventories

-

Total Current Assets

1121275000

Property Plant Equipment

55524000

Total Assets

1196031000

Payables

6109000

Short Term Debt

6441000

Long Term Debt

-

Total Liabilities

123862000

Equity

1072169000

Depreciation

1012000

Change In Working Capital

-1495000

Cash From Operations

-110718000

Capital Expenditures

863000

Cash From Investing

164809000

Cash From Financing

3084000

Net Change In Cash

57175000

PE

-

PB

4.436721589600147

ROE

-12.13344164959069

ROA

-10.876891986913382

FCF

-111581000

Fcf Percent

-780.2867132867133

Piotroski FScore

1

Health Score

30

Deep Value Investing Score

3

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

4.8

Garp Investing Score

2.5

Growth Investing Score

1

Momentum Investing Score

5

Net Net Investing Score

2.5

Quality Investing Score

2.5

Value Investing Score

3

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

143000

Quarters > 0 > income Statement > cost Of Revenue

90464000

Quarters > 0 > income Statement > gross Profit

-90321000

Quarters > 0 > income Statement > operating Expenses

52265000

Quarters > 0 > income Statement > operating Income

-142586000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-130091000

Quarters > 0 > income Statement > net Income

-130091000

Quarters > 0 > income Statement > eps

-1.3807886217693572

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

94215000

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-129079000

Quarters > 0 > income Statement > operating Margin

-99710.48951048951

Quarters > 0 > income Statement > total Other Income Expense Net

12495000

Quarters > 0 > balance Sheet > cash

110901000

Quarters > 0 > balance Sheet > short Term Investments

981390000

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

1121275000

Quarters > 0 > balance Sheet > property Plant Equipment

55524000

Quarters > 0 > balance Sheet > total Assets

1196031000

Quarters > 0 > balance Sheet > payables

6109000

Quarters > 0 > balance Sheet > short Term Debt

6441000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

123862000

Quarters > 0 > balance Sheet > equity

1072169000

Quarters > 0 > cash Flow > net Income

-130091000

Quarters > 0 > cash Flow > depreciation

1012000

Quarters > 0 > cash Flow > change In Working Capital

-1495000

Quarters > 0 > cash Flow > cash From Operations

-110718000

Quarters > 0 > cash Flow > capital Expenditures

863000

Quarters > 0 > cash Flow > cash From Investing

164809000

Quarters > 0 > cash Flow > cash From Financing

3084000

Quarters > 0 > cash Flow > net Change In Cash

57175000

Quarters > 0 > ratios > PE

-1.3807886217693572

Quarters > 0 > ratios > PB

4.436721589600147

Quarters > 0 > ratios > ROE

-12.13344164959069

Quarters > 0 > ratios > ROA

-10.876891986913382

Quarters > 0 > ratios > FCF

-111581000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-780.2867132867133

Quarters > 0 > health Score

30

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

1031000

Quarters > 1 > income Statement > cost Of Revenue

959000

Quarters > 1 > income Statement > gross Profit

1031000

Quarters > 1 > income Statement > operating Expenses

130143000

Quarters > 1 > income Statement > operating Income

-129112000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-115637000

Quarters > 1 > income Statement > net Income

-115637000

Quarters > 1 > income Statement > eps

-1.2329221353861244

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

93791000

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-128153000

Quarters > 1 > income Statement > operating Margin

-12522.987390882638

Quarters > 1 > income Statement > total Other Income Expense Net

13475000

Quarters > 1 > balance Sheet > cash

53726000

Quarters > 1 > balance Sheet > short Term Investments

1142634000

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

1217264000

Quarters > 1 > balance Sheet > property Plant Equipment

56572000

Quarters > 1 > balance Sheet > total Assets

1289574000

Quarters > 1 > balance Sheet > payables

11325000

Quarters > 1 > balance Sheet > short Term Debt

6610000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

118048000

Quarters > 1 > balance Sheet > equity

1171526000

Quarters > 1 > cash Flow > net Income

-115637000

Quarters > 1 > cash Flow > depreciation

959000

Quarters > 1 > cash Flow > change In Working Capital

6602000

Quarters > 1 > cash Flow > cash From Operations

-85851000

Quarters > 1 > cash Flow > capital Expenditures

3202000

Quarters > 1 > cash Flow > cash From Investing

37953000

Quarters > 1 > cash Flow > cash From Financing

7055000

Quarters > 1 > cash Flow > net Change In Cash

-40843000

Quarters > 1 > ratios > PE

-1.2329221353861244

Quarters > 1 > ratios > PB

4.042170289007671

Quarters > 1 > ratios > ROE

-9.870630271970063

Quarters > 1 > ratios > ROA

-8.967069745512859

Quarters > 1 > ratios > FCF

-89053000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-86.37536372453928

Quarters > 1 > health Score

30

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

361000

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

361000

Quarters > 2 > income Statement > operating Expenses

111766000

Quarters > 2 > income Statement > operating Income

-111405000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-96774000

Quarters > 2 > income Statement > net Income

-96774000

Quarters > 2 > income Statement > eps

-1.0394406135206549

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

93102000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-110480000

Quarters > 2 > income Statement > operating Margin

-30860.110803324103

Quarters > 2 > income Statement > total Other Income Expense Net

14631000

Quarters > 2 > balance Sheet > cash

94569000

Quarters > 2 > balance Sheet > short Term Investments

1179555000

Quarters > 2 > balance Sheet > receivables

7314000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

1291055000

Quarters > 2 > balance Sheet > property Plant Equipment

55322000

Quarters > 2 > balance Sheet > total Assets

1361327000

Quarters > 2 > balance Sheet > payables

9842000

Quarters > 2 > balance Sheet > short Term Debt

6883000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

107327000

Quarters > 2 > balance Sheet > equity

1254000000

Quarters > 2 > cash Flow > net Income

-96774000

Quarters > 2 > cash Flow > depreciation

925000

Quarters > 2 > cash Flow > change In Working Capital

-9537000

Quarters > 2 > cash Flow > cash From Operations

-88452000

Quarters > 2 > cash Flow > capital Expenditures

1239000

Quarters > 2 > cash Flow > cash From Investing

-85961000

Quarters > 2 > cash Flow > cash From Financing

4437000

Quarters > 2 > cash Flow > net Change In Cash

-169976000

Quarters > 2 > ratios > PE

-1.0394406135206549

Quarters > 2 > ratios > PB

3.7485805263157896

Quarters > 2 > ratios > ROE

-7.717224880382775

Quarters > 2 > ratios > ROA

-7.108798988046222

Quarters > 2 > ratios > FCF

-89691000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-248.45152354570638

Quarters > 2 > health Score

30

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

1227000

Quarters > 3 > income Statement > gross Profit

188000

Quarters > 3 > income Statement > operating Expenses

94745000

Quarters > 3 > income Statement > operating Income

-94745000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-80595000

Quarters > 3 > income Statement > net Income

-80595000

Quarters > 3 > income Statement > eps

-0.8808774345858745

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

91494000

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-93957000

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

14150000

Quarters > 3 > balance Sheet > cash

264545000

Quarters > 3 > balance Sheet > short Term Investments

1089524000

Quarters > 3 > balance Sheet > receivables

8470000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

1375388000

Quarters > 3 > balance Sheet > property Plant Equipment

55575000

Quarters > 3 > balance Sheet > total Assets

1434592000

Quarters > 3 > balance Sheet > payables

5853000

Quarters > 3 > balance Sheet > short Term Debt

7152000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

109787000

Quarters > 3 > balance Sheet > equity

1324805000

Quarters > 3 > cash Flow > net Income

-80595000

Quarters > 3 > cash Flow > depreciation

788000

Quarters > 3 > cash Flow > change In Working Capital

-308000

Quarters > 3 > cash Flow > cash From Operations

-64674000

Quarters > 3 > cash Flow > capital Expenditures

1029000

Quarters > 3 > cash Flow > cash From Investing

-542088000

Quarters > 3 > cash Flow > cash From Financing

554038000

Quarters > 3 > cash Flow > net Change In Cash

-52724000

Quarters > 3 > ratios > PE

-0.8808774345858745

Quarters > 3 > ratios > PB

3.4869524647023526

Quarters > 3 > ratios > ROE

-6.083536822400277

Quarters > 3 > ratios > ROA

-5.617973612009547

Quarters > 3 > ratios > FCF

-65703000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

38

Valuation > metrics > PE

-1.3807886217693572

Valuation > metrics > PB

4.436721589600147

Valuation > final Score

35.63278410399853

Valuation > verdict

47.9% Overvalued

Profitability > metrics > ROE

-12.13344164959069

Profitability > metrics > ROA

-11.602060154734566

Profitability > metrics > Net Margin

-909.7272727272727

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.11552469806532366

Risk > metrics > Interest Coverage

-140.89525691699606

Risk > final Score

-504

Risk > verdict

High

Liquidity > metrics > Current Ratio

89.34462151394422

Liquidity > metrics > Quick Ratio

89.34462151394422

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

39.57829710992329

Prev Valuations > 1

42.5141947368421

Prev Valuations > 2

45.130475352976475

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

15

Prev Risks > 0

19

Prev Risks > 1

27

Prev Risks > 2

32

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:21:56.815Z